ArticleSubstance abuse2019
Pharmacists' attitudes toward dispensing naloxone and medications for opioid use disorder: A scoping review of the literature.
Article in Substance abuse, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
37 citing papers in PubMed, 68 citations in OpenAlex.
- Assessing Readiness of Health Professions Students to Work With Patients Who Use Drugs: Construct Validity of the REDUCE-HARM Addiction Curricula Survey Tool.Substance use & addiction journal · 2026Article
- Barriers and facilitators to methadone dispensing for opioid use disorder in community pharmacies: A scoping review.Drug and alcohol dependence reports · 2026Review
- Practical naloxone communication tips for pharmacists: Lessons learned from the Linguistic Model of Patient Participation in Care.Research in social & administrative pharmacy : RSAP · 2025Article
- Community pharmacy attitudes and behaviors following a buprenorphine best practices dissemination.The mental health clinician · 2025Article
- Development of a brief stigma and perceptions questionnaire for pharmacists: An exploratory factor analysis approach in New York state counties enrolled in the healing communities study.Journal of substance use and addiction treatment · 2025Article
- A theoretical explanation of naloxone provision among primary care physicians and community pharmacists in Tennessee.Research in social & administrative pharmacy : RSAP · 2024Article
- Attitudes toward and training in medications for opioid use disorders: a descriptive analysis among employees in the youth legal system and community mental health centers.Substance abuse treatment, prevention, and policy · 2024Article
- Empowering Pharmacists: Strategies for Addressing the Opioid Crisis through a Public Health Lens.Pharmacy (Basel, Switzerland) · 2024Article
- Article
- Exploring the impact of brief training on student pharmacists' naloxone communication skills.PEC innovation · 2023Article
- Assessing suboxone access in community pharmacies: Secret shopper model.Exploratory research in clinical and social pharmacy · 2023Article
- Naloxone Accessibility Under the State Standing Order Across Mississippi.JAMA network open · 2023Article
- Will the End of the X-Waiver Expand Access to Buprenorphine Treatment? Achieving the Full Potential of the 2023 Consolidated Appropriations Act.Substance abuse · 2023Article
- Opioid Use Disorder Curricular Content in US-Based Doctor of Pharmacy Programs.American journal of pharmaceutical education · 2023Article
- Community-Centered Patient Journey Map in Opioid Use Disorder: A Tool to Address Compassion Fatigue among Community Pharmacists.Pharmacy (Basel, Switzerland) · 2023Article
- Factors in rural community buprenorphine dispensing.Exploratory research in clinical and social pharmacy · 2023Article
- Developing a single-session strategy for the implementation of take-home naloxone by community pharmacists using COM-B and design-thinking.Frontiers in health services · 2023Article
- Patient-reported problems filling buprenorphine prescriptions and motivations for illicit use.Drug and alcohol dependence reports · 2022Article
- Availability of medications for opioid use disorder in outpatient and inpatient pharmacies in South Florida: a secret shopper survey.Addiction science & clinical practice · 2022Article
- Improving Uptake of Emergency Department-initiated Buprenorphine: Barriers and Solutions.The western journal of emergency medicine · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 3 institutions in 1 country.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.